Rosopatamab, CAS [[2260767-49-3]]

Produktübersicht

• Artikelname: Rosopatamab, CAS [[2260767-49-3]]
• Artikelnummer: TGM-T78286
• Hersteller Artikelnummer: T78286
• Alternativnummer: TGM-T78286-1MG,TGM-T78286-5MG,TGM-T78286-10MG,TGM-T78286-25MG,TGM-T78286-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: HJ591 , HJ 591

Produktbeschreibung

Rosopatamab is a humanized monoclonal antibody targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer. It can be conjugated with radiolabeled isotopes (e.g., 177Lu) via DOTA-NHS ester to form radiopharmaceuticals for targeted therapy. In preclinical studies, 177Lu-DOTA-Rosopatamab combined with the DNA-PK inhibitor Peposertib achieved a 75% complete response rate in prostate cancer mouse models.

Produkteigenschaften

• Reinheit: >95.0%
• CAS Nummer: [2260767-49-3]
• Target-Kategorie: PSMA